Web Research
Web Research — The Campbell's Company (CPB)
The Bottom Line from the Web
Beyond the 10-K, the web tells a much harsher story: Snacks operating earnings collapsed roughly 39% YoY in Q2 FY26, FY26 EPS guidance was cut to $2.15–$2.25 (down 23–26% versus FY25), S&P revised the outlook to Negative and Fitch already downgraded the issuer to BBB-, and a securities class action was filed against the company on March 11, 2026. The stock has fallen ~39% over the trailing year to roughly $20, leaving CPB among the smallest S&P 500 names with a ~7.65% dividend yield that several credit and sell-side analysts now openly question. The thesis question on the internet has shifted from "turnaround stock" to "fallen angel and dividend cut watch."
What Matters Most
CPB Price (May 2026)
1-Year Total Return
Dividend Yield
Median Analyst Target
FY26 Guidance Mid (EPS)
FY26 EPS Growth (Mid)
1. Q2 FY26 was a clear break — guidance was cut hard, and the Snacks business is in distress.
On March 11, 2026, Campbell's reported Q2 FY26 adjusted EPS of $0.51 (down 31% YoY) versus consensus of $0.57, and cut full-year FY26 adjusted EPS guidance to $2.15–$2.25 from $2.40–$2.55 (a 23–26% decline vs FY25). Adjusted EBIT fell 24% to $282M; gross margin compressed to 28.0% from 30.5%. Source: Campbell's Q2 FY26 release · Reuters.
2. The Snacks segment is the single biggest problem — operating earnings collapsed roughly 39% YoY.
S&P Global flagged a ~39% YoY decline in adjusted EBIT for the Snacks business in Q2 FY26 (Fitch's later note cited 41%). Organic Snacks sales fell ~6%; chips were called out as "aggressive competition" and Goldfish volume is declining. CFO Todd Cunfer on the Q2 call: "We have to get Goldfish volume going in the right direction, or we will continue to have these margin hurts." Sources: S&P Global · Q2 FY26 transcript via Motley Fool · Perplexity bear-case summary.
3. Credit is moving against the company — S&P Negative, Fitch downgrade, "fallen angel" risk emerging.
Fitch downgraded CPB to BBB-/F3 on Dec 10, 2025, then revised the outlook to Negative on Mar 20, 2026. S&P revised its outlook to Negative on Mar 11, 2026, affirming BBB-/A-3 — but warned leverage could reach mid-to-high 4x by FYE26 vs. the 4x downgrade threshold. S&P-adjusted EBITDA margin is projected to fall from ~19.5% in FY24 to ~15.8% in FY26. A further notch lower would knock CPB out of investment grade. Sources: Fitch (Dec 2025) · Fitch (Mar 2026) · S&P Global.
4. The 7.65% dividend yield is now being openly debated as a "yield trap" — even by S&P.
With FY26 guidance of $2.15–$2.25 EPS and an annualized dividend of $1.56, payout ratio sits around 70–85% (and near 100% on some TTM measures). S&P explicitly stated CPB "may need to consider a cut to its payout in order to support its financial policy if operating performance does not improve." Buybacks have already been paused and dividend increases halted. Multiple sell-side notes (Seeking Alpha "Wise Owl", AInvest) call a cut "not out of the question" within 6–12 months.
5. A securities class action was filed the same day Q2 results dropped.
Levi & Korsinsky LLP filed a class action against CPB on March 11, 2026, on behalf of investors related to recent guidance/disclosures. The complaint coincides with the Q2 miss and FY26 cut. Separately, the DOJ/EPA Clean Water Act suit (March 2024, N.D. Ohio, Napoleon plant) remains in settlement discussion. Source: Levi & Korsinsky case page · Q2 FY26 10-Q via SEC.
6. Sell-side has turned decisively negative — 4+ downgrades in 90 days, Bernstein the latest.
Bernstein (Alexia Howard) downgraded CPB from Outperform → Market Perform on April 27, 2026, cutting the price target from $27 to $21. UBS cut its target to $20 with a Sell rating; Stifel cut to $20; Barclays maintained Sell at $21; Morgan Stanley cut to $23; TD Cowen $24; RBC $26; BofA Underperform at $23; Zacks moved from Hold to Strong Sell on Mar 12, 2026. MarketBeat aggregate is "Reduce" across 22 analysts. Sources: Bernstein via Investing.com · MarketBeat forecast · Stockanalysis.com.
7. Repeated trademark impairments signal that the Sovos-era Snacks acquisitions were over-valued.
Trademark impairments — all in Snacks — totaled $176M ($131M after-tax) in the first nine months of FY25: Snyder's of Hanover $150M (Q3 FY25), Late July $11M, and Allied brands (Tom's, Jays, Kruncher's, O-Ke-Doke, Stella D'oro, Archway) $15M. FY24 charges totaled $129M ($98M after-tax), including Pop Secret $76M and Allied $53M. Pop Secret was subsequently sold (Aug 26, 2024) and noosa yogurt divested Feb 24, 2025. Remaining Snyder's carrying value is widely flagged as a further impairment risk if Snacks volumes don't stabilize. Source: Q3 FY25 release.
8. CEO change is non-obvious — Clouse left to run the NFL Washington Commanders, mid-turnaround.
Mark Clouse announced his retirement on Dec 3, 2024, to become President of the NFL's Washington Commanders, effective Feb 1, 2025. He was succeeded by Mick Beekhuizen (CFO 2019–2022; President M&B 2022–2025; ex-Chobani CFO, ex-Goldman MD). Clouse said he was "stepping away a bit earlier than I anticipated." A new CFO (Todd Cunfer, ex-Hershey) joined Oct 7, 2025, and a new Snacks President (Mohit Anand, ex-Kellanova) joined Feb 23, 2026 — meaning the entire C-suite running the segment in distress is new. Sources: Business Wire (Dec 3, 2024) · Washington Post · Food Dive on Anand.
9. Insider sold meaningfully two months before the Q2 miss — open-market, not a 10b5-1.
Charles A. Brawley III (EVP / General Counsel / Corporate Secretary) sold 11,550 shares for $325,075 on Dec 31, 2025, at $28.14/share. This was an open-market transaction (no 10b5-1 plan disclosed) representing 20.88% of his direct holdings. Stock has since fallen to ~$20. Source: Motley Fool filings recap.
10. Stock is near multi-decade valuation lows and at risk of S&P 500 ejection.
At ~$20 and a market cap of roughly $6.1–6.4B, CPB is among the three smallest constituents of the S&P 500. Motley Fool and others flagged that continued weakness could trigger removal from the index, a forced-seller event for index funds. 1-year total return is -38.76%, 3-year -57.50%, YTD 2026 -24.57%. Source: Motley Fool, Mar 2026.
Recent News Timeline
The timeline shows three distinct phases: the Sovos-era growth narrative (2024), the leadership transition (late 2024 / early 2025), and the post-Q1 FY26 deterioration — credit downgrade, guidance cut, class action, and a wave of analyst cuts all clustering in March–April 2026.
What the Specialists Asked
Governance and People Signals
The pattern is unusual. Within ~12 months, CPB replaced its CEO, CFO, Snacks division head, and Chief IR Officer — essentially the entire leadership team facing the Snacks crisis is new. The General Counsel's open-market sale of 20.88% of his stake at $28 (versus the current ~$20 price) is the only non-grant insider transaction of meaningful size and is worth pairing with the timing of the Q2 miss and the March 2026 class action.
The Dorrance family aggregate stake of ~16–20% (across three vehicles) plus two board seats is the dominant governance feature. S&P explicitly notes this concentration in its credit rationale. Practically, this means the company is shielded from a hostile activist campaign — for better (continuity for the turnaround) and for worse (limited external pressure to cut the dividend, divest Snacks, or reset the cost base faster).
Auditor: PricewaterhouseCoopers (PwC) — reappointed at the November 18, 2025 annual meeting. No restatement, material-weakness disclosure, or auditor change identified in the research window.
Industry Context
The web research confirms three industry forces specifically pressuring CPB beyond what the filings emphasize:
1. Private label is now competing in premium tiers, not just value. Walmart's Bettergoods and Costco's Kirkland have both launched premium soup and pasta sauce alternatives, threatening Rao's pricing umbrella and Campbell's core soup pricing. This is a structural change — historical private-label competition was largely confined to value tiers.
2. Frito-Lay's promotional intensity is structural. S&P Global specifically flagged the chips category's "aggressive competition" as a driver of margin compression. CPB cannot match Frito-Lay's scale, and management has chosen volume loss over headline price cuts. This dynamic does not reverse with cyclical recovery.
3. Affordability rotation is hurting branded packaged food broadly. Reuters explicitly framed Campbell's FY26 guidance cut as driven by "budget-conscious consumers' shift toward cheaper alternatives." Peer consumer-staples names (General Mills, Conagra, Hormel) are also under pressure, but CPB is rated "Reduce" while many peers are "Hold" — implying the market believes CPB's mix (heavy Snacks) makes the affordability rotation hurt more here than at peers.
GLP-1 impact is referenced as a generic CPG headwind in CPB's Sept 2024 Investor Day materials but has not been quantified by the company. Analysts treat it as a long-tail demand risk on indulgent snacks (Goldfish, cookies, Pepperidge Farm baked goods) rather than soup or sauce. There is no specific quantified disclosure to react to today, but it should be watched in conjunction with Snacks volume trends.
Tariffs (tinplate steel for cans; Italian tomato/sauce imports) are a material in-period cost: ~$0.10/share in H1 FY26 alone, called out as a driver of the guidance cut. This is a CPB-specific story given the can-and-jar packaging mix — peers without metal/glass exposure are less affected.